Call for Science

Heart Rhythm 2017, which will be held May 10-13 in Chicago, IL, is the premier event for leading cardiac arrhythmia professionals from across the globe to network with colleagues, exchange ideas, and share groundbreaking research.

The Late Breaking Clinical Trials Submission Site is now open! The deadline to submit your science is Friday, March 10, 2017 at 11:59 p.m. EST. Accepted submissions will be published in the June Supplement of the HeartRhythm Journal.

Submitters are encouraged to use the Late-Breaking Clinical Trial Submission Guidelines as a tool for success. The resources includes everything you need to know about submitting a Late-Breaking Clinical Trial for presentation at the Annual Scientific Sessions.

Submission Guidelines include:

  • Important Information
  • Submitting Author Designation
  • Criteria
  • Rules for Submission Eligibility
  • Investigator Requirements
  • Abstract Submission & Preparation Guidelines
  • Acceptance & Registration Information

  • Abstract Submission Guideline Requirements

    Author Designation Information: The Submitting Author is the Presenting Author and listed as the First Author for all abstracts. The contact information of the submitter of the abstract will automatically populate the submission information for the Presenting Author and First Author fields. All correspondence and registration information for the abstract will be directed to the Submitting Author only. The Submitting Author is responsible for making sure that their contact information is current during the submission process.

    Authors should carefully consider the designation of the Submitting/Presenting/First Author before initiating the abstract submission process. Each Submitting Author will be asked to provide a username and password to sign-on to the Abstract Submission Site. If you do not have a username/password or have forgotten the information, instructions are provided on the submission site to assist you. The Submitting Author's information will pre-populate as the Presenting Author and First Author information fields upon signing into the submission site.

    Registration: The Presenting Author (Submitting Author) is required to register for Scientific Sessions at the reduced registration fee. Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter. Only one author per abstract is considered the presenter. Co-Author(s) listed on the abstract do not receive reduced rates towards registration. For more information, please review the Presenter Registration Information page.

    Embargo Policy
    Regular Abstract Submission: All abstracts are embargoed until the time of presentation. This means that information regarding any abstract submission may not be released before this time. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.

    Late-Breaking Clinical Trials Submission: Accepted Late-Breaking Clinical Trials abstracts are embargoed until the time of presentation.  This means that the Society will release these abstracts the day of the presentation/session.

    Duplicate Submissions: Abstract presented prior to the 38th Annual Scientific Sessions with substantially similar materials at any major North American meeting will be disqualified.

    Industry Abstract Submissions: Abstract submissions from industry representatives are allowed. Submissions are required to focus on science and research and not on specific products or services. Abstract presentation may NOT be sales presentations and/or endorsement for products or services.

    Abstract Acceptance and Withdrawal

    The Presenting Author must submit a request via email to the following address to withdraw an abstract from Heart Rhythm 2017 ( Please note that the Presenting Author will receive an e-mail confirmation upon completion of the withdrawal. The request must fulfill the following requirements:

    • Subject line of the e-mail must include "Abstract Withdrawal"
    • Inclusion of abstract title and number
    • Reason for the withdrawal

    The deadline to withdraw an abstract and avoid publication in the May 2017 issue of HeartRhythm Journal is Friday, February 10, 2017, 11:59 p.m. ET.


Withdrawal Policy

To withdraw an abstract from Heart Rhythm 2017 the Presenting Author must submit a request in writing to by February 10, 2017, 11:59 p.m. ET


Embargo Policy

All abstracts are embargoed until the time of presentation. The society will release these abstracts the day of presentation.


Contact Us

If you have questions or comments about abstracts, please contact the Heart Rhythm Society at